Hair treatment systems and methods using peptides and other compositions

• US 9,314,423 B2
• Filed: 03/13/2013
• Issued: 04/19/2016
• Est. Priority Date: 03/13/2013
• Status: Active Grant

• Current Assignee: Transdermal Biotechnology, Inc.
• Original Assignee: Transdermal Biotechnology, Inc.
• Inventors: Perricone, Nicholas V.
• Primary Examiner(s): Maewall, Snigdha
• Application Number:
  US13/801,488
• Publication Number:
  US 20140271810A1
• Time in Patent Office: 1,133 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 2800/74 Biological properties of particular ingredients
• CPC Class Codes: A61K 33/00 Medicinal preparations containing inorganic active ingredients
• CPC Class Codes: A61K 38/066 TRH, thyroliberin, thyrotropin releasing hormone
• CPC Class Codes: A61K 8/06 Emulsions
• CPC Class Codes: A61K 8/19 containing inorganic ingredients
• CPC Class Codes: A61K 8/553 Phospholipids, e.g. lecithin
• CPC Class Codes: A61K 8/64 Proteins; Peptides; Derivatives or degradation products thereof
• CPC Class Codes: A61K 9/0014 Skin, i.e. galenical aspects of topical compositions non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00
• CPC Class Codes: A61L 2/00 Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for contact lenses A61L12/00; atomisers for disinfecting agents A61M; sterilisation of packages or package contents in association with packaging B65B55/00; treatment of water, waste water, sewage or sludge C02F; disinfecting paper D21H21/36; disinfecting devices for water closets E03D; articles having provision for disinfection, see the relevant subclasses for these articles, e.g. H04R1/12
• CPC Class Codes: A61L 9/00 Disinfection, sterilisation or deodorisation of air body deodorants A61Q15/00; purifying air by respirators A62B, A62D9/00; separating dispersed particles from gases or vapours B01D45/00 - B01D51/00, B03C3/00; chemical or biological purification of waste gases B01D53/34; production of ozone C01B13/10; air-conditioning systems incorporating sterilisation F24F3/16, F24F8/20
• CPC Class Codes: A61P 17/14 for baldness or alopecia
• CPC Class Codes: A61Q 7/00 Preparations for affecting hair growth

Abstract

The present invention generally relates to compositions and methods for transdermal delivery, and treatment of hair related conditions. The compositions can be used in a variety of applications, including causing or promoting hair growth and/or hair pigmentation. In some cases, the composition may include nitric oxide and/or peptides. The nitric oxide and/or peptide may be present within a first phase comprising a lecithin, such as phosphatidylcholine. In certain embodiments, the lecithin is present in liposomes, micelles, or other vesicles containing nitric oxide, peptides, or both. The composition can take the form of a gel, a cream, a lotion, an ointment, a solution, a solid “stick,” etc., that can be rubbed or sprayed onto the skin, e.g., onto the scalp, or other suitable portion of the skin. Other aspects of the present invention are generally directed to methods of making or using such compositions, methods of promoting such compositions, kits including such compositions, or the like.

Claims

1. A method, comprising:

administering, to the skin and/or hair of a subject, a composition comprising an effective amount of thyrotropin-releasing hormone (TRH) and molecular nitric oxide to increase hair growth, and a carrier having a phosphatidylcholine component entrapping the molecular nitric oxide, wherein the molecular nitric oxide is present within the carrier as a gas or bound by hydrogen bonds or van der Waals forces, wherein the composition is stable at room temperature.

2. The method of claim 1, comprising administering the composition to the skin or hair of the head of the subject.

3. The method of claim 1, wherein the subject has greying hair.

4. The method of claim 1, wherein the subject has thinning hair.

5. The method of claim 1, wherein the subject has baldness.

6. The method of claim 1, wherein the subject has androgenic alopecia.

7. The method of claim 1, wherein the phosphatidylcholine carrier stabilizes the nitric oxide at a temperature at or lower than 80°

C.

8. The method of claim 1, wherein the composition comprises a liquid crystal structure comprising the phosphatidylcholine.

9. The method of claim 8, wherein at least a portion of the liquid crystal structure is multilamellar.

10. A method, comprising contacting the skin and/or hair of a subject with a composition comprising:

an emulsion comprising a first phase comprising TRH, molecular nitric oxide, and lecithin, and a second phase comprising an emulsifier, wherein the lecithin is present at least about 0.25% by weight of the composition, wherein the first phase comprises no more than about 250 ppm of water by weight of the composition, and wherein the molecular nitric oxide is present within the emulsion as a gas or bound by hydrogen bonds or van der Waals forces to the lecithin.

11. The method of claim 10, comprising administering the composition to the skin or hair of the head of the subject.

12. The method of claim 10, wherein the subject has greying hair.

13. The method of claim 10, wherein the subject has thinning hair.

14. The method of claim 10, wherein the subject has baldness.

15. The method of claim 10, wherein the subject has androgenic alopecia.

16. The method of claim 10, wherein the first phase forms discrete vesicles contained within the second phase.

17. The method of claim 16, wherein the first phase forms liposomes contained within the second phase.

18. The method of claim 17, wherein the first phase forms multilamellar liposomes contained within the second phase.

19. The method of claim 10, wherein the nitric oxide is present at least about 0.5% by weight of the composition without nitric oxide.

20. The method of claim 10, wherein at least some of the nitric oxide is present within the first phase bound to phosphatidylcholine.

21. The method of claim 10, wherein the lecithin comprises a phosphatidylcholine.

22. The method of claim 21, wherein at least some of the phosphatidylcholine comprises a polyenylphosphatidylcholine.

23. The method of claim 10, wherein the first phase comprises a fatty acid ester.

24. A method, comprising:

administering, topically to the skin of a subject, a composition comprising an effective amount of thyrotropin-releasing hormone (TRH) molecular nitric oxide and phosphatidylcholine to increase hair growth, wherein the composition is a cream, a gel, a lotion, or an ointment, and wherein the composition comprises no more than about 250 ppm of water by weight of the composition.

25. The method of claim 24, comprising administering the composition to the skin or hair of the head of the subject.

26. The method of claim 24, wherein the subject has thinning hair or baldness.

27. The method of claim 24, wherein the subject has androgenic alopecia.

28. The method of claim 24, wherein the composition comprises a liquid crystal structure comprising the phosphatidylcholine.

29. The method of claim 28, wherein at least a portion of the liquid crystal structure is multilamellar.

30. The method of claim 24, wherein at least some of the phosphatidylcholine comprises a polyenylphosphatidylcholine.

31. The method of claim 24, wherein the composition is a cream.